Michael A. Metzger, Chief Executive Officer at Syndax Pharmaceuticals Inc (SNDX), sold 11,918 shares at $27.64 ($329K) on 2023-02-06, disclosed to the SEC on 2023-02-08.
Seasonal sale ($329k) by Chief Executive Officer — this insider has traded SNDX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.64 | 5,959 | $165K | 50.0% |
| 2 | $27.64 | 5,959 | $165K | 50.0% |
| Total | $27.64 avg | 11,918 | $329K | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |